ATAI
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
13 of 31
Similar slides by ATAI
See diffirences between slides (animation)
Investor Conference
May 2023
phase trial design randomized week study of and placebo in patients with | ATAI
Investor Presentation
April 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Investor Presentation
February 2023
phase proof of concept trial design all subjects tid tid placebo trial status recruitment ongoing results anticipated randomized week study of and in patients with | ATAI
Investor Presentation
January 2023
phase proof of concept trial design all subjects tid tid placebo trial status recruitment ongoing results anticipated randomized week study of and in patients with | ATAI
Related slides by other companies
Adagio Therapeutics
Investor Presentation
May 2023
ongoing phase trial of with initial data planned for | Adagio Therapeutics
Arbutus Biopharma
Investor Presentation
January 2024
phase a clinical trial | Arbutus Biopharma
Erasca
Investor Presentation
November 2023
anticipated key milestones and clinical trial | Erasca
Erasca
Investor Presentation
November 2023
proposed pivotal phase trial designs creative strategy includes high randomized melanoma trial and tissue agnostic indication | Erasca
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights